Breast cancer risk prediction with a modified BOADICEA model in Danish women.
Saved in:
| Title: | Breast cancer risk prediction with a modified BOADICEA model in Danish women. |
|---|---|
| Authors: | Novitski SI; Translational Disease Systems Biology, Novo Nordisk Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Jacobsen RL; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark., Röder T; Translational Disease Systems Biology, Novo Nordisk Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Holm PC; Translational Disease Systems Biology, Novo Nordisk Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Schwinn M; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark., Vejborg I; Department of Breast Examinations, Copenhagen University Hospital, Herlev Gentofte, Copenhagen, Denmark., von Euler-Chelpin MC; Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Lynge E; Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Ostrowski SR; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Sørensen E; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark., Pedersen OB; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark., Erikstrup C; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Aagaard B; Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark., Hjalgrim H; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Haematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.; Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark., Rafnar T; deCODE genetics/Amgen, Reykjavik, Iceland., Stefansson K; deCODE genetics/Amgen, Reykjavik, Iceland., Mavaddat N; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Ficorella L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Ullum H; Statens Serum Institute, Copenhagen, Denmark., Banasik K; Translational Disease Systems Biology, Novo Nordisk Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.; Department of Obstetrics and Gynaecology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark., Brunak S; Translational Disease Systems Biology, Novo Nordisk Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Bojesen SE; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. stig.egil.bojesen@regionh.dk.; Department of Clinical Biochemistry, Copenhagen University Hospital, Herlev Gentofte, Copenhagen, Denmark. stig.egil.bojesen@regionh.dk. |
| Corporate Authors: | DBDS Genomic Consortium |
| Source: | British journal of cancer [Br J Cancer] 2026 Jan; Vol. 134 (2), pp. 259-268. Date of Electronic Publication: 2025 Nov 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
